Remove Contract research organization Remove Ecosystems Remove Engineering
article thumbnail

ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform

Frost & Sullivan

The open architecture of these solutions allows them to integrate with customers’ wider IT ecosystems inside and outside the safety domain. Our end-to-end drug development technology platform, LifeSphere ® , integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle.

article thumbnail

Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. He holds a masters degree in biomedical engineering from the University of Michigan-Ann Arbor.

Biotech 52